Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-30 @ 3:29 PM
Study NCT ID:
NCT05433532
Status:
COMPLETED
Last Update Posted:
2024-04-25
First Post:
2022-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-13
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-14
First Submit QC Date:
None
Study First Post Date:
2022-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-24
Last Update Post Date:
2024-04-25
Last Update Post Date Type:
ACTUAL